Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium phosphate monobasic monohydrate + sodium phosphate dibasic anhydrous is a combination osmotic laxative used primarily for bowel cleansing prior to colonoscopy or other imaging procedures. The drug acts by drawing water into the colon through its osmotic effect, leading to diarrhea and effective evacuation of the bowel contents. This allows for improved visualization during diagnostic procedures. It is available in both oral tablet and intravenous forms; the oral form is used as a purgative for colon cleansing while the intravenous form serves as an electrolyte replenisher in clinical settings where phosphorus supplementation is required[1][3][4][5][7][8]. The mechanism of action involves increasing intraluminal fluid volume in the intestine via osmotic activity of phosphates.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sodium phosphate monobasic monohydrate + sodium phosphate dibasic anhydrous.